← Leaderboards
Wang-Xia Wang
University Of Kentucky
$1,975,255
Attributed
$1,975,255
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $667K · FY2023–25$1M$750K$500K$250K$0
'23
'24
'25
Funding mix
By agency
NIH$1,975,255 · 1
By mechanism
R01$1,975,255 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Kentucky
Same institution · by research overlap
- Zhenheng Guo$9,758,888
- Kurt Francis Hauser$27,368,955
- Patrick G Sullivan$10,466,531
- Craig T. Jordan$14,848,921
- Ming C Gong$10,288,417
Others in their field
Other Rising Stars on “Alzheimer&Apos”
- Kjetil Bjornevik · Harvard University D/B/A Harvard School Of Public Health$3,280,861
- Yanling Wang · Rush University Medical Center$2,986,919
- William G Mantyh · University Of Minnesota$2,961,521
- Allison Mercedes Caban-Holt · University Of Miami School Of Medicine$2,611,182
- Brian Stephen Appleby · Cleveland Clinic Lerner Com-Cwru$2,482,260
- Noah Ray Johnson · University Of Colorado Denver$2,282,487
Research focus
Alzheimer&AposAgedBrain TissueAffectBone MarrowApolipoprotein EBehavioral AssayBiobankAllelesBiologicalFemaleBrainBrain CellBrain InjuriesAgingCcaat-Enhancer-Binding Protein-BetaCellsCell SeparationDementiaBiochemicalEfficacy TestingEventAcuteFunding
Grant awards (3)
MicroRNA lipid-nanoparticle based therapy targets neuroinflammation and ApoE dysregulation in Alzheimerâs disease$653,652
R01 · FY2025 · AG · contact PI
MicroRNA lipid-nanoparticle based therapy targets neuroinflammation and ApoE dysregulation in Alzheimerâs disease$666,990
R01 · FY2024 · AG · contact PI
MicroRNA lipid-nanoparticle based therapy targets neuroinflammation and ApoE dysregulation in Alzheimerâs disease$654,613
R01 · FY2023 · AG · contact PI